Results 231 to 240 of about 72,997 (336)
ABSTRACT Congenital syngnathia, the rare fusion of the maxilla and mandible, poses significant feeding and respiratory challenges. Its management is complicated by rarity and potential syndromic associations. We present a 1‐week‐old female neonate who presented with left jaw deviation, respiratory distress (SpO2 69%, tachypnea), and fever.
Asteway M. Haile +5 more
wiley +1 more source
The impact of maternal systemic diseases on the occurrence of cleft lip and palate in newborns: a narrative review. [PDF]
Sui H +6 more
europepmc +1 more source
Mechanisms of Improving Feeding Function With Capsaicin Following Local Anesthesia in Infant Pigs
With inferior alveolar nerve anesthetization, we found changes in some behavioral variables, as well as a decrease in bolus sizes and improved airway protection. This highlights the tradeoff between feeding efficiency and feeding safety. With capsaicin administration, some behavioral variables were returned to baseline values fully or partially, which ...
Chloe E. Edmonds +8 more
wiley +1 more source
Awareness and knowledge of impression techniques for cleft lip and palate among dentists: A cross-sectional survey. [PDF]
D V +6 more
europepmc +1 more source
Postoperative Outcome of Prelaminated Radial Forearm Free Flap for Soft Palate Reconstruction
ABSTRACT Objectives One method for the reconstruction of the entire soft palate is to use prelaminated radial forearm flaps (PRFFF). In a two‐step procedure the back of the flap is first epithelialized with split‐skin and subsequently used for soft palate reconstruction. Limited data exist on the perioperative and postoperative course of this technique.
Zhaojun Zhu +8 more
wiley +1 more source
Caries status among 6-year-old children born with cleft lip and palate in Norway: a nationwide study. [PDF]
Osman OE +7 more
europepmc +1 more source
Lysine Acetyltransferase 6 in Health and Disease
KAT6A and its paralog KAT6B have emerged as druggable targets for the treatment of malignancies, especially for breast cancer. Recent progress in drug discovery has promoted the development of dual inhibitors targeting KAT6A and KTA6B, which shows potent antitumor efficacy and manageable toxicity.
Yujing Tan, Jiani Wang, Fei Ma
wiley +1 more source

